Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptide

US Patent 9884907 · Granted Feb 6, 2018

Estimated economic value: $121,698,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against signal-regulatory protein alpha and methods of use2025
Anti-Sortilin antibodies and methods of use thereof2025
Combination therapies comprising a hypomethylation agent for treating cancer2025
Anti-MS4A4A antibodies and methods of use thereof2025
Anti-MS4A4A antibodies and methods of use thereof2025
Anti-TMEM106B antibodies and methods of use thereof2025
Anti-sortilin antibodies and methods of use thereof2025
Anti-Siglec-5 antibodies and methods of use thereof2025
Anti-SIRPα antibodies and methods of use thereof2025
Anti-CD33 antibodies and methods of use thereof2025
Anti-SIRP-alpha antibodies and methods of use thereof2025
Anti-Siglec-7 antibodies and methods of use thereof2025